http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006022011-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e11815dee6df9a74cfdb05a0a282703b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 |
| filingDate | 2004-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cdb841fd02bbcb46fca7f3062e9e3b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_726533f0b24773d1b498547de114f619 |
| publicationDate | 2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006022011-A |
| titleOfInvention | Transdermal preparation |
| abstract | [PROBLEMS] To reduce the release of drugs and changes in blood concentration of drugs over time due to fluctuations in manufacturing conditions, excellent product quality stability, and sufficient and stable drug efficacy. To provide a tulobuterol-containing transdermal absorption preparation. SOLUTION: In a percutaneous absorption-type preparation in which an adhesive composition layer containing an adhesive and tulobuterol is formed on one side of a support, 0.5 to 3% by weight of tulobuterol is contained in the adhesive composition layer. Is contained in a dissolved state, and the pressure-sensitive adhesive composition layer has a thickness exceeding 100 μm and not more than 300 μm. [Selection] Figure 3 |
| priorityDate | 2004-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.